XML 17 R6.htm IDEA: XBRL DOCUMENT v3.8.0.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
6 Months Ended
Mar. 31, 2018
Mar. 31, 2017
Operating Activities:    
Net (loss) $ (1,222,344) $ (514,329)
Adjustments to reconcile net loss to net cash provided by operating activities:    
Depreciation and amortization 193,809 62,834
Warranty provision 12,361 111,369
Inventory obsolescence 85,435 (181,486)
Share-based compensation 284,250 642,151
Deferred income taxes 2,867,339 (317,243)
Changes in operating assets and liabilities:    
Accounts receivable, net 389,434 168,183
Inventories, net (271,543) (174,720)
Prepaid expenses and other 174,589 (101,304)
Other assets (60,614) 133,188
Accounts payable 502,933 707,549
Accrued and other liabilities (56,313) 521,375
Net cash provided by operating activities 2,899,336 1,057,567
Investing Activities:    
Purchases of marketable securities (2,402,346) (1,773,530)
Proceeds from maturities of marketable securities 2,401,856 1,874,823
Capital expenditures (90,135) (57,473)
Patent costs paid (4,286)
Purchase of Genasys, net of cash and restricted cash acquired (2,246,545)
Net cash (used in) provided by investing activities (2,337,170) 39,534
Financing Activities:    
Proceeds from exercise of stock options 185,718
Proceeds from issuance of unsecured promissory notes 63,144
Payments on unsecured promissory notes (414,477)
Net cash used in financing activities (165,615)
Effect of foreign exchange rate on cash 335
Net increase in cash, cash equivalents and restricted cash 396,886 1,097,101
Cash, cash equivalents and restricted cash, beginning of period 12,803,887 13,466,711
Cash, cash equivalents and restricted cash, end of period 13,200,773 14,563,812
Reconciliation of cash, cash equivalents and restricted cash to the condensed consolidated balance sheets:    
Total cash, cash equivalents, and restricted cash shown in the condensed consolidated statements of cash flows 12,803,887 13,466,711
Supplemental disclosures of cash flow information:    
Interest paid 9,186
Noncash investing and financing activities:    
Change in unrealized loss on marketable securities (16,868) (1,978)
Business combinations accounted for as a purchase:    
Fair value of assets acquired 5,520,504
Cash paid or payable (3,011,439)
Liabilities assumed $ 2,509,065